0 seconds of 2 minutes, 39 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
02:39
02:39
 
  • Else Nutrition (BABY) has concluded a preclinical study on its plant-based, soy-free infant formula
  • This study demonstrates the safety and nutrient bioavailability of the Else infant formula
  • Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition sat down with Shoran Devi to discuss the news
  • Else Nutrition is focused on developing innovative, clean and plant-based food and nutrition products
  • Else Nutrition Holdings (BABY) is currently trading at C$1.16 per share

Else Nutrition (BABY) has concluded a preclinical study on its plant-based, soy-free infant formula, on the pathway to bring its formulation to market.

This successful trial marks the key first step on the path with the Food and Drug Administration (FDA), as well as with other regulatory authorities, to demonstrate the safety and nutrient bioavailability of the Else infant formula.

Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition sat down with Shoran Devi to discuss the news.

Else Nutrition is focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula.

Else Nutrition Holdings (BABY) is currently trading at C$1.16 per share.

Latest News
More C.AYUR news on Stockhouse »
Latest Bullboard Posts
  • Trading today
    It seems to me someones wife wanted to go on vacation today,enjoy Cuba Who...
    March 4, 2025
  • Q2 results
    https://stockhouse.com/news/press-releases/2025/02/27/ayurcann-reports-another-record-sales-growth-in-q2-2025-of-13-363-509
    February 27, 2025
More bullboard posts for C.AYUR on Stockhouse »
More From The Market Online
Stock image generated with AI

@ the Bell: Market chaos drags TSX to 7-month low

The TSX plummeted on Monday as recession concerns grew, following US President Donald Trump's unwavering stance on his extensive tariff plans.
Stock chart with arrow pointing down into the ground

@ the Bell: TSX tumbles again

The TSX plummeted on Friday, as a global selloff intensified due to China’s retaliatory measures against US tariffs.
Rocket ship shooting from light bulb investment concept

The 5-Minute Investor Podcast, Ep. 5: High-flying stocks

Welcome to The 5-Minute Investor, a podcast by Stockhouse, featuring columnists Jonathon Brown and Trevor Abes.
AI generated stock market image

@ the Bell: TSX sinks under fears of reciprocal tariffs

The TSX dropped hard on Thursday, dragged down by energy and mining stocks, as reciprocal US tariffs heightened fears.